SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-058159
Filing Date
2023-12-18
Accepted
2023-12-18 16:28:19
Documents
4
Period of Report
2024-01-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20015850x2_def14a.htm DEF 14A 195779
2 logo_transcode.jpg GRAPHIC 19427
3 ny20015850x2_pc01.jpg GRAPHIC 553638
4 ny20015850x2_pc02.jpg GRAPHIC 596194
  Complete submission text file 0001140361-23-058159.txt   1806232
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40363 | Film No.: 231494127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)